SMSbiotech is proud to welcome Steven N. Copp, MD, Chair of the Department of Orthopedic Surgery at Scripps Clinic Medical Group and the Scripps Medical Foundation, as a valued advisor and collaborator.
This collaboration represents an important step in SMSbiotech’s mission to advance breakthrough therapies. Following the success of its first-in-human clinical trial in COPD, SMSbiotech is now preparing to initiate a new program focused on orthopedic joint conditions, including osteoarthritis.
Encouraged by outstanding results from the treatment of clinical animal cases in joint disease, SMSbiotech is building strong momentum toward human applications in orthopedics, strengthened by the expertise of its clinical collaborators.
Conclusion
This is some text inside of a div block.
